|
|
Volumn 14, Issue 5, 2000, Pages 616-617
|
|
The costs of antiretroviral drug wastage
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRETROVIRUS AGENT;
DIDANOSINE;
INDINAVIR;
LAMIVUDINE;
NELFINAVIR;
RITONAVIR;
SAQUINAVIR;
STAVUDINE;
ZIDOVUDINE;
BUDGET;
CANADA;
DEATH;
DRUG COST;
DRUG USE;
DRUG WITHDRAWAL;
GASTROINTESTINAL SYMPTOM;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INCOME;
LETTER;
MAJOR CLINICAL STUDY;
PALLIATIVE THERAPY;
PATIENT EDUCATION;
PRESCRIPTION;
PRIORITY JOURNAL;
RESOURCE MANAGEMENT;
SIDE EFFECT;
SOCIAL PSYCHOLOGY;
TREATMENT PLANNING;
ANTI-HIV AGENTS;
CANADA;
DRUG COSTS;
HUMANS;
|
|
EID: 0034119060
PISSN: 02699370
EISSN: None
Source Type: Journal
DOI: 10.1097/00002030-200003310-00018 Document Type: Letter |
|
Times cited : (1)
|
|
References (8)
|
